Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin 
secretion from mouse and human pancreatic islets.

Jain, Ruchi; Jain, D; Liu, Q; Bartosinska, B; Wang, J; Schumann, D; Kauschke, S G; Eickelmann, Peter; Piemonti, Lorenzo; Gray, N S; Lammert, Eckhard

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets.

MPS-Authors

/persons/resource/persons219265

Jain, Ruchi
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

/persons/resource/persons219367

Lammert, Eckhard
Max Planck Institute of Molecular Cell Biology and Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Jain, R., Jain, D., Liu, Q., Bartosinska, B., Wang, J., Schumann, D., et al. (2013). Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets. Diabetologia, 56(6), 1350-1355.

Cite as: https://hdl.handle.net/21.11116/0000-0001-0720-3

Abstract

Type 2 diabetes is characterised by impaired glucose-stimulated insulin secretion (GSIS) from pancreatic islets. Since erythropoietin-producing hepatoma (Eph)-ephrin bidirectional signalling fine-tunes GSIS from pancreatic beta cells, we investigated Eph receptor tyrosine kinases (RTK) as potential drug targets for selectively increasing GSIS.